Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	32.95	21.21	15.95
Graham Fair Price	-86.83	2.07	15.69
PEG	40110.87	3.19	< 0.005
Price/Book	-4.46	1.69	1.77
Price/Cash Flow	1298.73	106.22	7.59
Prices/Earnings	5385.20	-324.26	5.91
Price/Sales	5.76	2.07	1.95
Price/FCF	1298.73	106.22	7.59
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	-40.24	0.35	0.58
Operating Margin	215.87	0.35	0.11
ROA	-98.17	< 0.005	0.02
ROE	0.07	< 0.005	-98.26
ROIC	0.03	0.14	307.59
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	-0.78	3.80	-79.40
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	0.65	1.84	184.50
EPS QOQ	7.45	-1.02	-86.36
FCF QOQ	6.29	-0.93	-85.18
Revenue QOQ	0.03	-0.10	221.31
Naive Interpretation	member

03 - Financial Growth · Balanced

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	2.12	2.15	1.55
Days Sales Outstanding (DSO)	50.06	60.61	21.07
Inventory Turnover	42.48	41.83	-1.52
Debt/Capitalization	0.59	0.24	-59.49
Quick Ratio	1.11	1.09	-1.45
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	12.09	12.06	-0.22
Cash	6.87	4.21	-38.80
Capex	-0.61	-0.35	42.30
Free Cash Flow	2.82	0.19	-93.18
Revenue	10.95	9.87	-9.87
Naive Interpretation	member

05 - Per Share Metrics · Bad

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	1.24	1.23	-0.72
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	5.15	-0.21	-95.86
Naive Interpretation	Member

06 - Financial Health · Weak

Rating